Literature DB >> 18954850

Long-term significance of Killip class and left ventricular systolic dysfunction.

Kapil Parakh1, Brett D Thombs, Utsav Bhat, James A Fauerbach, David E Bush, Roy C Ziegelstein.   

Abstract

BACKGROUND: Killip classification is an independent predictor of early mortality after myocardial infarction, and the presence of left ventricular systolic dysfunction (left ventricular ejection fraction <50%) and high Killip class predicts poor short-term prognosis. The long-term prognostic significance of Killip class and left ventricular systolic dysfunction, however, is unknown.
METHODS: We studied the impact of Killip class and left ventricular systolic dysfunction on all-cause mortality (assessed in May 2007 using the Social Security Death Index) in myocardial infarction patients admitted from July 1995 to December 1996.
RESULTS: Of 282 patients, 60% (n=168) were Killip class 1, 23% (n=64) were Killip class 2, and 17% (n=50) were Killip class 3 or 4. Patients with higher Killip class were older and more likely to have diabetes, a non-Q-wave myocardial infarction, renal insufficiency, chronic obstructive pulmonary disease, and left ventricular systolic dysfunction. There were 152 deaths at 10 years after myocardial infarction, and patients with Killip class 2, 3, or 4 had higher mortality compared with Killip class 1 in unadjusted analyses. Patients with left ventricular systolic dysfunction and Killip class of 2 or more had significantly higher 10-year mortality (70 deaths or 76.9%) compared with Killip class 1 patients without left ventricular systolic dysfunction (29 deaths or 34.5%, P <.001). This risk persisted after adjusting for demographics, cardiovascular risk factors, and co-morbidities. Much of the risk was explained by deaths in the first 5 years after myocardial infarction.
CONCLUSIONS: Killip class is a strong predictor of long-term mortality, and patients with high Killip class and left ventricular systolic dysfunction are at highest risk.

Entities:  

Mesh:

Year:  2008        PMID: 18954850     DOI: 10.1016/j.amjmed.2008.06.020

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

1.  Effect of abnormal fasting plasma glucose level on all-cause mortality in older patients with acute myocardial infarction: results from the Beijing Elderly Acute Myocardial Infarction Study (BEAMIS).

Authors:  Shi-Wei Yang; Yu-Jie Zhou; Xiao-Min Nie; Yu-Yang Liu; Jie Du; Da-Yi Hu; De-An Jia; Fei Gao; Bin Hu; Zhe Fang; Hong-Ya Han; Xiao-Li Liu; Zhen-Xian Yan; Jian-Long Wang; Qi Hua; Yu-Jie Shi; Hong-Wei Li
Journal:  Mayo Clin Proc       Date:  2011-02       Impact factor: 7.616

Review 2.  Heart failure after myocardial infarction: clinical implications and treatment.

Authors:  Marcos F Minicucci; Paula S Azevedo; Bertha F Polegato; Sergio A R Paiva; Leonardo A M Zornoff
Journal:  Clin Cardiol       Date:  2011-06-17       Impact factor: 2.882

3.  Biases in Individualized Cost-effectiveness Analysis: Influence of Choices in Modeling Short-Term, Trial-Based, Mortality Risk Reduction and Post-Trial Life Expectancy.

Authors:  David van Klaveren; John B Wong; David M Kent; Ewout W Steyerberg
Journal:  Med Decis Making       Date:  2017-03-20       Impact factor: 2.583

4.  Postmortem diagnosis of acute myocardial infarction in patients with acute respiratory failure: demographics, etiologic and pulmonary histologic analysis.

Authors:  Alexandre de Matos Soeiro; Aline D Ruppert; Mauro Canzian; Vera L Capelozzi; Carlos V Serrano
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

5.  Sex dependent risk factors for mortality after myocardial infarction: individual patient data meta-analysis.

Authors:  Hanna M van Loo; Edwin R van den Heuvel; Robert A Schoevers; Matteo Anselmino; Robert M Carney; Johan Denollet; Frank Doyle; Kenneth E Freedland; Sherry L Grace; Seyed H Hosseini; Kapil Parakh; Louise Pilote; Chiara Rafanelli; Annelieke M Roest; Hiroshi Sato; Richard P Steeds; Ronald C Kessler; Peter de Jonge
Journal:  BMC Med       Date:  2014-12-17       Impact factor: 8.775

6.  Prognostic value of TIMI score versus GRACE score in ST-segment elevation myocardial infarction.

Authors:  Luis C L Correia; Guilherme Garcia; Felipe Kalil; Felipe Ferreira; Manuela Carvalhal; Ruan Oliveira; André Silva; Isis Vasconcelos; Caio Henri; Márcia Noya-Rabelo
Journal:  Arq Bras Cardiol       Date:  2014-07-15       Impact factor: 2.000

7.  Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction.

Authors:  Hirofumi Hioki; Hirohiko Motoki; Atsushi Izawa; Yuichirou Kashima; Takashi Miura; Souichirou Ebisawa; Takeshi Tomita; Yusuke Miyashita; Jun Koyama; Uichi Ikeda
Journal:  Heart Vessels       Date:  2015-04-12       Impact factor: 2.037

8.  General glycosylated hemoglobin goals potentially increase myocardial infarction severity in diabetes patients with comorbidities: Insights from a nationwide multicenter study.

Authors:  Qianzi Che; Yan Zhang; Jianan Wang; Zheng Wan; Xianghua Fu; Jiyan Chen; Hongbing Yan; Yundai Chen; Junbo Ge; Dafang Chen; Yong Huo
Journal:  J Diabetes Investig       Date:  2020-06-13       Impact factor: 4.232

9.  Risk Assessment of Patients After ST-Segment Elevation Myocardial Infarction by Killip Classification: An Institutional Experience.

Authors:  Kashif A Hashmi; Fahar Adnan; Omer Ahmed; Syed Rafay Yaqeen; Javaria Ali; Muhammad Irfan; Muhammad M Edhi; Atif A Hashmi
Journal:  Cureus       Date:  2020-12-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.